About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Veterinary Oncology Market Size, Top Share, Report to 2032
Veterinary Oncology Market

Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy, Targeted Therapy, Others), By Animal Type (Canine, Feline, Others), By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary and Squamous Cell Cancer, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI945DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Veterinary Oncology Market Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Surgery
        1. By Value
      3. Radiology
        1. By Value
      4. Chemotherapy
        1. By Value
      5. Immunotherapy
        1. By Value
      6. Targeted Therapy
        1. By Value
      7. Others
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Canine
        1. By Value
      3. Feline
        1. By Value
      4. Others
        1. By Value
    4. By Cancer Type
      1. Introduction
        1. Cancer Type By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Mammary and Squamous Cell Cancer
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Surgery
        1. By Value
      3. Radiology
        1. By Value
      4. Chemotherapy
        1. By Value
      5. Immunotherapy
        1. By Value
      6. Targeted Therapy
        1. By Value
      7. Others
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Canine
        1. By Value
      3. Feline
        1. By Value
      4. Others
        1. By Value
    4. By Cancer Type
      1. Introduction
        1. Cancer Type By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Mammary and Squamous Cell Cancer
        1. By Value
      5. Others
        1. By Value
    5. U.S.
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Surgery
          1. By Value
        3. Radiology
          1. By Value
        4. Chemotherapy
          1. By Value
        5. Immunotherapy
          1. By Value
        6. Targeted Therapy
          1. By Value
        7. Others
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Canine
          1. By Value
        3. Feline
          1. By Value
        4. Others
          1. By Value
      3. By Cancer Type
        1. Introduction
          1. Cancer Type By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Mammary and Squamous Cell Cancer
          1. By Value
        5. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Surgery
        1. By Value
      3. Radiology
        1. By Value
      4. Chemotherapy
        1. By Value
      5. Immunotherapy
        1. By Value
      6. Targeted Therapy
        1. By Value
      7. Others
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Canine
        1. By Value
      3. Feline
        1. By Value
      4. Others
        1. By Value
    4. By Cancer Type
      1. Introduction
        1. Cancer Type By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Mammary and Squamous Cell Cancer
        1. By Value
      5. Others
        1. By Value
    5. U.K.
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Surgery
          1. By Value
        3. Radiology
          1. By Value
        4. Chemotherapy
          1. By Value
        5. Immunotherapy
          1. By Value
        6. Targeted Therapy
          1. By Value
        7. Others
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Canine
          1. By Value
        3. Feline
          1. By Value
        4. Others
          1. By Value
      3. By Cancer Type
        1. Introduction
          1. Cancer Type By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Mammary and Squamous Cell Cancer
          1. By Value
        5. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Surgery
        1. By Value
      3. Radiology
        1. By Value
      4. Chemotherapy
        1. By Value
      5. Immunotherapy
        1. By Value
      6. Targeted Therapy
        1. By Value
      7. Others
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Canine
        1. By Value
      3. Feline
        1. By Value
      4. Others
        1. By Value
    4. By Cancer Type
      1. Introduction
        1. Cancer Type By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Mammary and Squamous Cell Cancer
        1. By Value
      5. Others
        1. By Value
    5. China
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Surgery
          1. By Value
        3. Radiology
          1. By Value
        4. Chemotherapy
          1. By Value
        5. Immunotherapy
          1. By Value
        6. Targeted Therapy
          1. By Value
        7. Others
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Canine
          1. By Value
        3. Feline
          1. By Value
        4. Others
          1. By Value
      3. By Cancer Type
        1. Introduction
          1. Cancer Type By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Mammary and Squamous Cell Cancer
          1. By Value
        5. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Surgery
        1. By Value
      3. Radiology
        1. By Value
      4. Chemotherapy
        1. By Value
      5. Immunotherapy
        1. By Value
      6. Targeted Therapy
        1. By Value
      7. Others
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Canine
        1. By Value
      3. Feline
        1. By Value
      4. Others
        1. By Value
    4. By Cancer Type
      1. Introduction
        1. Cancer Type By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Mammary and Squamous Cell Cancer
        1. By Value
      5. Others
        1. By Value
    5. UAE
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Surgery
          1. By Value
        3. Radiology
          1. By Value
        4. Chemotherapy
          1. By Value
        5. Immunotherapy
          1. By Value
        6. Targeted Therapy
          1. By Value
        7. Others
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Canine
          1. By Value
        3. Feline
          1. By Value
        4. Others
          1. By Value
      3. By Cancer Type
        1. Introduction
          1. Cancer Type By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Mammary and Squamous Cell Cancer
          1. By Value
        5. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Surgery
        1. By Value
      3. Radiology
        1. By Value
      4. Chemotherapy
        1. By Value
      5. Immunotherapy
        1. By Value
      6. Targeted Therapy
        1. By Value
      7. Others
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Canine
        1. By Value
      3. Feline
        1. By Value
      4. Others
        1. By Value
    4. By Cancer Type
      1. Introduction
        1. Cancer Type By Value
      2. Lymphoma
        1. By Value
      3. Mast Cell Cancer
        1. By Value
      4. Mammary and Squamous Cell Cancer
        1. By Value
      5. Others
        1. By Value
    5. Brazil
      1. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Surgery
          1. By Value
        3. Radiology
          1. By Value
        4. Chemotherapy
          1. By Value
        5. Immunotherapy
          1. By Value
        6. Targeted Therapy
          1. By Value
        7. Others
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Canine
          1. By Value
        3. Feline
          1. By Value
        4. Others
          1. By Value
      3. By Cancer Type
        1. Introduction
          1. Cancer Type By Value
        2. Lymphoma
          1. By Value
        3. Mast Cell Cancer
          1. By Value
        4. Mammary and Squamous Cell Cancer
          1. By Value
        5. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Veterinary Oncology Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. PetCure Oncology
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Accuray Incorporated
    3. Varian Medical Systems
    4. Boehringer Ingelheim
    5. Elanco
    6. Zoetis Karyopharm Therapeutics, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Veterinary Endoscopy Market Size The global veterinary endoscopy market size was valued at USD 195 million in 2021 and is projected to reach USD 300 million by 2030, growing at a CAGR of 5.7% during the forecast period (2022
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.